George Jaise Mariya, Mathew Beena
School of Chemical Sciences, Mahatma Gandhi University, Kottayam, Kerala, 686560 India.
Korean J Chem Eng. 2021;38(3):624-634. doi: 10.1007/s11814-020-0719-7. Epub 2021 Mar 5.
-Cyclodextrin (-CD) modified gold nanoparticles (AuNP) were rapidly synthesized using microwave assisted procedure. Parameters, such as time, pH and concentrations of -CD and gold, were optimized for the synthesis of -CD-AuNP. The addition of enantiomers and racemic mixture of hydroxychloroquine (R-HCQ, S-HCQ and RS-HCQ) drugs and their interaction with -CD led to a red shift in the surface plasmon resonance of -CD-AuNP. The changes associated with the introduction of HCQ in -CD-AuNP were studied using various characterization techniques such as UV-vis, FT-IR, XRD, dynamic light scattering, zeta potential, transmission electron microscopy, fluorescence spectroscopy and electrochemical techniques. The host-guest interaction of -cyclodextrin with S-HCQ, R-HCQ and RS-HCQ resulted in the aggregation of gold nanoparticles. The surface plasmon resonance at 521 nm for -CD-AuNP was shifted to 600, 620 and 670 nm on the addition of S-HCQ, R-HCQ and RS-HCQ, respectively, with a color change from pink to blue. The selectivity and sensitivity of the developed system for RS-HCQ were investigated and the limit of detection (LOD=3 s/m) was found to be 2.61, 0.15, and 0.85 nM for optical, fluorescence and electrochemical methods, respectively. The successful monitoring of RS-HCQ drug in pharmaceutical samples is possible with these techniques.
Supplementary material is available for this article at 10.1007/s11814-020-0719-7 and is accessible for authorized users.
使用微波辅助程序快速合成了β-环糊精(β-CD)修饰的金纳米颗粒(AuNP)。对合成β-CD-AuNP的时间、pH值以及β-CD和金的浓度等参数进行了优化。加入羟氯喹(R-HCQ、S-HCQ和RS-HCQ)药物的对映体和外消旋混合物及其与β-CD的相互作用导致β-CD-AuNP的表面等离子体共振发生红移。使用紫外可见光谱、傅里叶变换红外光谱、X射线衍射、动态光散射、zeta电位、透射电子显微镜、荧光光谱和电化学技术等各种表征技术研究了在β-CD-AuNP中引入HCQ所伴随的变化。β-环糊精与S-HCQ、R-HCQ和RS-HCQ的主客体相互作用导致金纳米颗粒聚集。加入S-HCQ、R-HCQ和RS-HCQ后,β-CD-AuNP在521 nm处的表面等离子体共振分别移至600、620和670 nm,颜色从粉红色变为蓝色。研究了所开发系统对RS-HCQ的选择性和灵敏度,发现光学、荧光和电化学方法的检测限(LOD = 3 s/m)分别为2.61、0.15和0.85 nM。使用这些技术可以成功监测药物样品中的RS-HCQ药物。
本文的补充材料可在10.1007/s11814-(此处数字可能有误,原文为10.1007/s11814-020-0719-7)获取,授权用户可访问。